GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioton SA (WAR:BIO) » Definitions » Short-Term Debt

Bioton (WAR:BIO) Short-Term Debt : zł37.0 Mil (As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Bioton Short-Term Debt?

Bioton's Short-Term Debt for the quarter that ended in Dec. 2024 was zł37.0 Mil.

Bioton's quarterly Short-Term Debt declined from Jun. 2024 (zł44.4 Mil) to Sep. 2024 (zł40.8 Mil) and declined from Sep. 2024 (zł40.8 Mil) to Dec. 2024 (zł37.0 Mil).

Bioton's annual Short-Term Debt declined from Dec. 2022 (zł55.3 Mil) to Dec. 2023 (zł52.9 Mil) and declined from Dec. 2023 (zł52.9 Mil) to Dec. 2024 (zł37.0 Mil).

Bioton Short-Term Debt Historical Data

The historical data trend for Bioton's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioton Short-Term Debt Chart

Bioton Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 70.79 78.62 55.31 52.85 36.96

Bioton Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.85 48.67 44.41 40.77 36.96

Bioton Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Bioton Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Bioton's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioton Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioton SA (WAR:BIO) » Definitions » Short-Term Debt
Comparable Companies
WAR:SVE WAR:MOC WAR:CTX WAR:PTG WAR:MAB WAR:BCX WAR:URT WAR:NNG WAR:RDG WAR:PHR VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Ul. Staro?ci?ska 5, Warszawa, POL, 02-516
Website
http://www.bioton.pl
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.